Muxol (Ambroxol Hydrochloride)

Ambroxol stimulates serous glands in the airway lining, increasing watery secretions, and enhances ciliary activity. This dual action reduces mucus viscosity and promotes faster clearance of secretions, making it easier to expectorate sputum and improve airway patency.

The appropriate dose of Muxol is determined by a qualified healthcare professional based on the patient’s age, condition severity, and overall health. Prescribers follow local guidelines and product labeling to set the exact regimen.

Safety data for ambroxol in pregnancy and lactation are limited. Healthcare providers should weigh potential benefits against possible risks and consider alternative treatments if safer options are available. Women who are pregnant or nursing should discuss use with their physician.

To request Muxol, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Compared with other expectorants such as guaifenesin, ambroxol (Muxol) not only thins mucus but also actively stimulates ciliary movement, offering a dual mechanism. This can result in more efficient clearance, especially in chronic conditions like COPD, whereas some alternatives act primarily by increasing fluid volume.

Muxol should be stored at room temperature, below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

Muxol is taken orally, usually as a tablet or liquid formulation, as directed by a healthcare professional. It should be swallowed with water and can be taken with or without food, unless the prescribing information advises otherwise.

Serious risks, though rare, include severe allergic reactions such as anaphylaxis, Stevens‑Johnson syndrome, and significant liver enzyme elevations. Patients should seek immediate medical attention if they experience rash, swelling, difficulty breathing, or jaundice.

Muxol should be avoided in individuals with known hypersensitivity to ambroxol or any excipients in the formulation. Caution is also advised for patients with severe renal impairment, uncontrolled asthma, or those taking medications that may interact significantly.